Showing 1 - 16 results of 16 for search 'Burmester G', query time: 0.04s
Refine Results
-
1
-
2
Cardiovascular safety - Update from up to 6 years of treatment with baricitinib in rheumatoid arthritis clinical trials by Weinblatt, M, Taylor, P, Burmester, G, Saifan, C, Walls, C, Issa, M, Rooney, T, Takeuchi, T
Published 2018Conference item -
3
-
4
Efficacy and safety of adalimumab (Humira (R)) in European clinical practice: The ReAct trial by Burmester, G, Wordsworth, P, Mariette, X, Saez, I, Bijlsma, J, Webber, D, Kupper, H
Published 2005Conference item -
5
Cardiovascular safety during treatment with baricitinib in rheumatoid arthritis by Weinblatt, M, Taylor, P, Burmester, G, Witt, S, Saifan, C, Walls, C, Rooney, T, Chen, L, Takeuchi, T
Published 2017Conference item -
6
-
7
-
8
-
9
-
10
BIK is a novel pro-apoptotic target gene for miR-125b in human monocytes by Fabre S, Pers Y M, Presumey J, Duroux-Richard I, Lecellier C H, Gruen J, Häupl T, Grützkau A, Burmester G, Jorgensen C, Apparailly F
Published 2010-11-01Article -
11
Cardiovascular safety during treatment with baricitinib in rheumatoid arthritis by Taylor, P, Weinblatt, M, Burmester, G, Rooney, T, Witt, S, Walls, C, Issa, M, Salinas, C, Saifan, C, Zhang, X, Cardoso, A, Gonzalez-Gay, M, Takeuchi, T
Published 2019Journal article -
12
Summary of indirect comparison to evaluate efficacy of baricitinib with targeted synthetic and biologic disease anti-rheumatic drugs in patients with rheumatoid arthritis by Emery, P, Dudler, J, Smolen, J, Zerbini, C, Burmester, G, Fautrel, B, Van Der Laar, M, Fleischmann, R, Fakhouri, W, De Leonardis, F, Zhu, B, Kadziola, Z, De La Torre, I, Perrier, C, Taylor, P
Published 2019Conference item -
13
“Evolving the management of RA” programme: educational tools to support daily practice by Burmester, G, Alvaro-Gracia, JM, Betteridge, N, Calvo-Alen, J, Combe, B, Durez, P, Ferreira, RJO, Fautrel, B, Iagnocco, A, Montecucco, C, Østergaard, M, Ramiro, S, Rubbert-Roth, A, Stamm, T, Szekanecz, Z, Taylor, PC, van de Laar, M
Published 2020Conference item -
14
Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis (May 2000). by Furst, D, Breedveld, F, Burmester, G, Crofford, J, Emery, P, Feldmann, M, Kalden, JR, Kavanaugh, A, Keystone, E, Klareskog, L, Lipsky, P, Maini, R, Russell, A, Scott, D, Smolen, J, Van de Putte, L, Visher, T, Weisman, M
Published 2000Journal article -
15
Evolving the management of rheumatoid arthritis (eRA) through development of practical and educational tools by Van De Laar, M, Álvaro-Gracia, J, Betteridge, N, Calvo Alén, J, Combe, B, Durez, P, Ferreira, R, Fautrel, B, Gabay, C, Iagnocco, A, Montecucco, C, Østergaard, M, Ramiro, S, Rubbert-Roth, A, Stamm, T, Szekanecz, Z, Taylor, P, Burmester, G
Published 2019Conference item -
16
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update by Smolen, J, Landewé, R, Bijlsma, J, Burmester, G, Chatzidionysiou, K, Dougados, M, Nam, J, Ramiro, S, Voshaar, M, van Vollenhoven, R, Aletaha, D, Aringer, M, Boers, M, Buckley, C, Buttgereit, F, Bykerk, V, Cardiel, M, Combe, B, Cutolo, M, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gomez-Reino, J, Gossec, L, Gottenberg, J, Hazes, J, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T, Li, Z, Mariette, X, McInnes, I, Mysler, E, Nash, P, Pavelka, K, Poór, G, Richez, C, van Riel, P, Rubbert-Roth, A, Saag, K, da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, de Wit, M, van der Heijde, D
Published 2017Journal article